176 related articles for article (PubMed ID: 15852403)
21. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
[TBL] [Abstract][Full Text] [Related]
22. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
Dodge JC; Treleaven CM; Fidler JA; Hester M; Haidet A; Handy C; Rao M; Eagle A; Matthews JC; Taksir TV; Cheng SH; Shihabuddin LS; Kaspar BK
Mol Ther; 2010 Dec; 18(12):2075-84. PubMed ID: 20859261
[TBL] [Abstract][Full Text] [Related]
23. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
24. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal Injection of scAAV9-hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway.
Hu H; Lin H; Duan W; Cui C; Li Z; Liu Y; Wang W; Wen D; Wang Y; Li C
Neuroscience; 2018 Jun; 381():1-10. PubMed ID: 29447858
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for ALS delivers.
Boillée S; Cleveland DW
Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis.
Dewil M; Lambrechts D; Sciot R; Shaw PJ; Ince PG; Robberecht W; Van den Bosch L
Neuropathol Appl Neurobiol; 2007 Oct; 33(5):499-509. PubMed ID: 17854437
[TBL] [Abstract][Full Text] [Related]
29. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
[TBL] [Abstract][Full Text] [Related]
30. DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis.
Spooren WP; Hengerer B
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):63-9. PubMed ID: 10726972
[TBL] [Abstract][Full Text] [Related]
31. Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside.
Gibson SB; Bromberg MB
Semin Neurol; 2012 Jul; 32(3):173-8. PubMed ID: 23117941
[TBL] [Abstract][Full Text] [Related]
32. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
33. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord.
Engesser-Cesar C; Anderson AJ; Cotman CW
Neuroscience; 2007 Feb; 144(3):1033-44. PubMed ID: 17137724
[TBL] [Abstract][Full Text] [Related]
34. Extensive exercise is not harmful in amyotrophic lateral sclerosis.
Liebetanz D; Hagemann K; von Lewinski F; Kahler E; Paulus W
Eur J Neurosci; 2004 Dec; 20(11):3115-20. PubMed ID: 15579165
[TBL] [Abstract][Full Text] [Related]
35. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
37. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis.
Karlsson J; Fong KS; Hansson MJ; Elmér E; Csiszar K; Keep MF
J Neurosurg; 2004 Jul; 101(1):128-37. PubMed ID: 15255263
[TBL] [Abstract][Full Text] [Related]
38. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.
Martin LJ; Liu Z
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1002-18. PubMed ID: 17984682
[TBL] [Abstract][Full Text] [Related]
39. Experimental therapies hold promise for treating amyotrophic lateral sclerosis.
Friedrich MJ
JAMA; 2005 Mar; 293(9):1048-9. PubMed ID: 15741517
[No Abstract] [Full Text] [Related]
40. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
